busy and colorful calendar
Biotech

Sanofi signs 2nd biotech deal of the day

Sanofi is paying Adel $80 million in cash, with the total deal potentially reaching up to $1.04 billion, plus royalties.
Gabrielle Masson Dec 15, 2025 5:50pm
runway takeoff airport cleared go

'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug

Dec 15, 2025 10:55am
OI956px x 537pxpng

A Defining Moment for Wound Care

Dec 15, 2025 8:00am
Sanofi

Sanofi's tolebrutinib woes pile up with FDA delay, trial miss

Dec 15, 2025 9:30am
Lab 956x537png

ADCs Mark a New Era in Targeted Cancer Therapy

Dec 15, 2025 8:00am
Darts failing to hit bullseye

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Dec 15, 2025 2:14pm
More News

Link emerges to connect CAR-T therapy across solid, liquid tumors

Dec 15, 2025 1:18pm

Chai infuses AI drug discovery efforts with $130M series B

Dec 15, 2025 11:11am

Pfizer, Sanofi round out '25 with separate autoimmune deals

Dec 15, 2025 11:06am

Immunome's desmoid tumor treatment triumphs in phase 3

Dec 15, 2025 10:42am